Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Bartoletti

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Journal of Chemotherapy (Florence, Italy)|February 12, 2026
Effectiveness of azacytidine for poly ADP-ribose polymerase inhibitor-induced myelodysplastic syndrome in ovarian cancer patient: a twofold triumphStefano Fucina, Riccardo Vida, Arianna Dri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulationKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Journal of Advanced Research|August 9, 2025
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responsesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.
Pharmaceutics|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug MonitoringGiovanni Canil, Marco Orleni, Bianca Posocco, et al.
Advances in Respiratory Medicine|June 27, 2023
Identify Drug-Resistant Pathogens in Patients with Community-Acquired PneumoniaFrancesco Amati, Francesco Bindo, Anna Stainer, et al.
British Journal of Clinical Pharmacology|July 3, 2026
Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropeniaChun Liu, Pier Giorgio Cojutti, J G Coen van Hasselt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2022
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida sppElisa Viciani, Paolo Gaibani, Andrea Castagnetti, et al.
ACS Omega|November 8, 2021
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer TherapyMuhammad Adeel, Salvatore Parisi, Matteo Mauceri, et al.
Expert Opinion on Drug Safety|December 25, 2023
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and futureDavide Fiore Bavaro, Alessandra Belati, Linda Bussini, et al.
Journal of Clinical Medicine|November 10, 2020
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal CancerFrancesco Londero, Orlando Parise, William Grossi, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Journal of Chemotherapy (Florence, Italy)|February 12, 2026
Effectiveness of azacytidine for poly ADP-ribose polymerase inhibitor-induced myelodysplastic syndrome in ovarian cancer patient: a twofold triumphStefano Fucina, Riccardo Vida, Arianna Dri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Copper nitroprusside: An innovative approach for targeted cancer therapy via ROS modulationKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Journal of Advanced Research|August 9, 2025
Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responsesEnrico Cavarzerani, Isabella Caligiuri, Michele Bartoletti, et al.
Pharmaceutics|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug MonitoringGiovanni Canil, Marco Orleni, Bianca Posocco, et al.
Advances in Respiratory Medicine|June 27, 2023
Identify Drug-Resistant Pathogens in Patients with Community-Acquired PneumoniaFrancesco Amati, Francesco Bindo, Anna Stainer, et al.
British Journal of Clinical Pharmacology|July 3, 2026
Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropeniaChun Liu, Pier Giorgio Cojutti, J G Coen van Hasselt, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 12, 2022
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida sppElisa Viciani, Paolo Gaibani, Andrea Castagnetti, et al.
ACS Omega|November 8, 2021
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer TherapyMuhammad Adeel, Salvatore Parisi, Matteo Mauceri, et al.
Expert Opinion on Drug Safety|December 25, 2023
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and futureDavide Fiore Bavaro, Alessandra Belati, Linda Bussini, et al.
Journal of Clinical Medicine|November 10, 2020
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal CancerFrancesco Londero, Orlando Parise, William Grossi, et al.
Pageof 21